Skip to main content
Kent Academic Repository

Browse by Person (creator, editor, contributor, etc.)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Walton, M. I. and Eve, P. D. and Hayes, A. and Valenti, M. R. and De Haven Brandon, A. K. and Box, G. and Hallsworth, A. and Smith, E. L. and Boxall, K. J. and Lainchbury, M. and Matthews, T. P. and Jamin, Y. and Robinson, S. P. and Aherne, G. W. and Reader, J. C. and Chesler, L. and Raynaud, F. I. and Eccles, S. A. and Collins, I. and Garrett, Michelle D. (2012) CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research, 18 (20). pp. 5650-5661. ISSN 1078-0432. (doi:https://doi.org/10.1158/1078-0432.CCR-12-1322) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

Walton, M. I. and Eve, P. D. and Hayes, A. and Valenti, M. and De Haven Brandon, A. and Box, G. and Boxall, K. J. and Aherne, G. W. and Eccles, S. A. and Raynaud, F. I. and Williams, D. H. and Reader, J. C. and Collins, I. and Garrett, Michelle D. (2010) The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106. Molecular Cancer Therapeutics, 9 (1). pp. 89-100. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-09-0938) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

This list was generated on Mon May 20 13:03:24 2019 BST.